Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Current Drug Delivery|May 30, 2012
Controlled and continuous release ocular drug delivery systems: pros and consHamdy Abdelkader, Raid G AlanyInternational Journal of Pharmaceutics|December 3, 2014
Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studiesHamdy Abdelkader, Barbara Pierscionek, Raid G AlanyThe Journal of Pharmacy and Pharmacology|February 4, 2015
Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lensHamdy Abdelkader, Raid G Alany, Barbara PierscionekNutrition (Burbank, Los Angeles County, Calif.)|June 29, 2010
Borage oil in the treatment of atopic dermatitisRachel H Foster, Gil Hardy, Raid G AlanyThe Journal of Pharmacy and Pharmacology|December 16, 2010
Effect of cations on the microstructure and in-vitro drug release of κ- and ι-carrageenan liquid and semi-solid aqueous dispersionsThilini Rasika Thrimawithana, Simon Young, Raid G AlanyBiomedicines|August 26, 2022
Eudragit® L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo EvaluationShahla Mirzaeei, Shiva Taghe, Raid G Alany, et al.Pharmaceutical Development and Technology|March 17, 2010
Phase behavior, rheological and mechanical properties of hydrophilic polymer dispersionsSushila Bhattarai, Craig Bunt, Michael Rathbone, et al.International Journal of Pharmaceutics|April 2, 2011
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro releaseIlva D Rupenthal, Colin R Green, Raid G AlanyOxidative Medicine and Cellular Longevity|November 9, 2016
On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor?Hamdy Abdelkader, Michael Longman, Raid G Alany, et al.Molecular Pharmaceutics|October 12, 2011
Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surfaceIlva D Rupenthal, Raid G Alany, Colin R GreenPageof 10